首页> 外国专利> METHODS FOR ASSESSING THE ABILITY OF HIV PATIENTS TO RESTRICT HIV REPLICATION

METHODS FOR ASSESSING THE ABILITY OF HIV PATIENTS TO RESTRICT HIV REPLICATION

机译:评估艾滋病毒患者限制艾滋病毒复制的能力的方法

摘要

There are provided methods for evaluating the effectiveness of HIV therapies and vaccines and methods for assessing the ability of HIV patients to restrict virus replication. Upon restimulation of CD8+T cells or peripheral blood mononuclear cells from a patient, proliferation of the CD8+T cells, the expression of perforin in these cells, and the cell cycle stage of these cells may be measured and used as in vitro markers for monitoring the patient's ability to restrict HIV replication and the effectiveness of the therapies and vaccines applied. Significant proliferation of CD8+T cell, the presence of perforin in these cells, and the ability of these cells to progress beyond the G1 stage signify the patient's ability to restrict HIV replication and a favorable effect of the therapies or vaccines. These methods may be advantageously applied in conjunction with other measurements of HIV specific immune response such as HLA tetramers.
机译:提供了用于评估HIV疗法和疫苗的有效性的方法以及用于评估HIV患者限制病毒复制的能力的方法。当来自患者的CD8 + T细胞或外周血单核细胞再刺激时,可以测量CD8 + T细胞的增殖,穿孔素在这些细胞中的表达以及这些细胞的细胞周期阶段,并将其用作用于监测患者限制HIV复制的能力以及所用疗法和疫苗的有效性的体外标记物。 CD8 + T细胞的显着增殖,这些细胞中穿孔素的存在,以及这些细胞超过G1期的能力表明该患者限制HIV复制的能力以及治疗或疫苗的有利作用。这些方法可以有利地与HIV特异性免疫应答的其他测量例如HLA四聚体结合应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号